Ludovic Martinet

8PUBLICATIONS
57CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyEpigenetics (incl. genome methylation and epigenomics)Molecular targetsTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 20, 2026
Molecular predictors of minimal residual disease in newly diagnosed multiple myeloma treated with quadruplet therapy.

|Oct 30, 2024
Forimtamig, a novel GPRC5D-targeting T-cell bispecific antibody with a 2+1 format, for the treatment of multiple myeloma.

Jan Eckmann, Tanja Fauti, Marlene Biehl

|Sep 04, 2024
Impact of the Multiple Sclerosis-Associated Genetic Variant CD226 Gly307Ser on Human CD8 T-Cell Functions.

Elena Morandi, Véronique Adoue, Isabelle Bernard

|Jun 14, 2024
NK cells with adhesion defects and reduced cytotoxic functions are associated with a poor prognosis in multiple myeloma.

Eve Blanquart, Rüçhan Ekren, Bineta Rigaud

|Apr 21, 2024
RAS/RAF landscape in monoclonal plasma cell conditions.

Anais Schavgoulidze, Jill Corre, Mehmet Kemal Samur

|Feb 24, 2022
SAR442085, a novel anti-CD38 antibody with enhanced antitumor activity against multiple myeloma.

Sahar Kassem, Béré K Diallo, Nizar El-Murr

Pageof 2

Frequent Collaborators

5 joint publications

Jill Corre

4 joint publications

Aurore Perrot

2 joint publications

Céline Chevalier

2 joint publications

Mehmet Kemal Samur